PL2309983T3 - Farmaceutyczna postać podawania zawierająca tetrahydrobiopterynę - Google Patents
Farmaceutyczna postać podawania zawierająca tetrahydrobiopterynęInfo
- Publication number
- PL2309983T3 PL2309983T3 PL09775591T PL09775591T PL2309983T3 PL 2309983 T3 PL2309983 T3 PL 2309983T3 PL 09775591 T PL09775591 T PL 09775591T PL 09775591 T PL09775591 T PL 09775591T PL 2309983 T3 PL2309983 T3 PL 2309983T3
- Authority
- PL
- Poland
- Prior art keywords
- tetrahydrobiopterin
- pharmaceutical form
- pharmaceutical
- Prior art date
Links
- FNKQXYHWGSIFBK-RPDRRWSUSA-N sapropterin Chemical compound N1=C(N)NC(=O)C2=C1NC[C@H]([C@@H](O)[C@@H](O)C)N2 FNKQXYHWGSIFBK-RPDRRWSUSA-N 0.000 title 1
- 229960004617 sapropterin Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT12542008 | 2008-08-12 | ||
| PCT/AT2009/000306 WO2010017570A2 (de) | 2008-08-12 | 2009-08-07 | Pharmazeutische darreichungsform enthaltend tetrahydrobiopterin |
| EP09775591.2A EP2309983B1 (de) | 2008-08-12 | 2009-08-07 | Pharmazeutische darreichungsform enthaltend tetrahydrobiopterin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2309983T3 true PL2309983T3 (pl) | 2019-09-30 |
Family
ID=41111155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL09775591T PL2309983T3 (pl) | 2008-08-12 | 2009-08-07 | Farmaceutyczna postać podawania zawierająca tetrahydrobiopterynę |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20110144117A1 (enExample) |
| EP (1) | EP2309983B1 (enExample) |
| JP (1) | JP2011530540A (enExample) |
| ES (1) | ES2736730T3 (enExample) |
| PL (1) | PL2309983T3 (enExample) |
| RU (1) | RU2011109210A (enExample) |
| TR (1) | TR201910287T4 (enExample) |
| WO (1) | WO2010017570A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20140108281A (ko) * | 2013-01-10 | 2014-09-05 | 뉴트리셔널 테라퓨틱스, 인크. | 건강 유지 및 급성 및 만성 장애의 치료를 위한 지질 보조제를 함유하는 츄어블 웨이퍼 |
| ES2586945T3 (es) * | 2014-03-31 | 2016-10-19 | Vasopharm Gmbh | Composiciones farmacéuticas sólidas que comprenden derivados de biopterina y usos de dichas composiciones |
| CN110312721A (zh) | 2016-11-29 | 2019-10-08 | 显莎制药公司 | 墨蝶呤的多晶型物 |
| WO2018102315A1 (en) * | 2016-11-29 | 2018-06-07 | Censa Pharmaceuticals Inc. | Polymoprhs of sepiapterin and salts thereof |
| MX2020002271A (es) * | 2017-09-01 | 2020-10-05 | Ptc Therapeutics Mp Inc | Composiciones farmaceuticas que comprenden sepiapterina y sus usos de las mismas. |
| CA3102105A1 (en) | 2018-05-30 | 2019-12-05 | Ptc Therapeutics Mp, Inc. | Compositions and methods for increasing tetrahydrobiopterin plasma exposure |
| JP7778477B2 (ja) | 2018-05-30 | 2025-12-02 | ピーティーシー セラピューティクス エムピー，インコーポレイテッド | セピアプテリンの薬学的に許容される塩 |
| JP7502197B2 (ja) | 2018-05-30 | 2024-06-18 | ピーティーシー セラピューティクス エムピー，インコーポレイテッド | セピアプテリン血漿曝露を増加させるための方法 |
| JP7553906B2 (ja) * | 2018-11-01 | 2024-09-19 | 宏 一瀬 | Ｓｐｒをコードするポリヌクレオチドを含む組換えベクター、及びそれを含む組成物 |
| LT4009978T (lt) | 2019-08-05 | 2024-11-25 | Ptc Therapeutics Mp, Inc. | Sepiapterino ir jo metabolitų panaudojimas spinduliuotės poveikio gydymui |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61277618A (ja) * | 1985-06-04 | 1986-12-08 | Suntory Ltd | 自閉症治療剤 |
| JP2588191B2 (ja) * | 1987-04-24 | 1997-03-05 | サントリー株式会社 | 悪性腫瘍および重症ウイルス感染症に伴う神経症状を改善するための治療剤 |
| DE10260263A1 (de) * | 2002-12-20 | 2004-07-15 | Biocrates Life Sciences Gmbh | Verwendung von Tetrahydrobiopterinderivaten zur Behandlung und Ernährung von Patienten mit Aminosäurestoffwechselstörungen |
| US20080207624A1 (en) * | 2004-05-11 | 2008-08-28 | Osamu Sugita | Therapeutic Agent for Bh4-Responsive Hyperphenylalaninemia |
| CN101132776A (zh) * | 2004-11-17 | 2008-02-27 | 生物马林药物股份有限公司 | 稳定的四氢生物喋呤片剂制剂 |
| US20060188492A1 (en) * | 2005-01-13 | 2006-08-24 | Chronorx Llc, An Alaska Limited Liability Company | Topical management of ocular and periocular conditions |
| JP2008540486A (ja) * | 2005-05-11 | 2008-11-20 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｐｄｅ４インヒビター及びテトラヒドロビオプテリン誘導体との組合せ物 |
| KR20160065998A (ko) * | 2007-04-11 | 2016-06-09 | 바이오마린 파머수티컬 인크. | 테트라하이드로바이오프테린 투여 방법, 관련 조성물 및 측정 방법 |
-
2009
- 2009-08-07 WO PCT/AT2009/000306 patent/WO2010017570A2/de not_active Ceased
- 2009-08-07 US US13/058,625 patent/US20110144117A1/en not_active Abandoned
- 2009-08-07 PL PL09775591T patent/PL2309983T3/pl unknown
- 2009-08-07 EP EP09775591.2A patent/EP2309983B1/de active Active
- 2009-08-07 JP JP2011522346A patent/JP2011530540A/ja active Pending
- 2009-08-07 TR TR2019/10287T patent/TR201910287T4/tr unknown
- 2009-08-07 ES ES09775591T patent/ES2736730T3/es active Active
- 2009-08-07 RU RU2011109210/15A patent/RU2011109210A/ru not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20110144117A1 (en) | 2011-06-16 |
| EP2309983B1 (de) | 2019-04-24 |
| TR201910287T4 (tr) | 2019-07-22 |
| ES2736730T3 (es) | 2020-01-07 |
| RU2011109210A (ru) | 2012-09-20 |
| WO2010017570A3 (de) | 2010-08-05 |
| JP2011530540A (ja) | 2011-12-22 |
| WO2010017570A2 (de) | 2010-02-18 |
| EP2309983A2 (de) | 2011-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL237391A0 (en) | Pharmaceutical combination | |
| IL228817A0 (en) | Pharmaceutical compounds | |
| IL207378A0 (en) | Pharmaceutical solid state forms | |
| GB0801416D0 (en) | Pharmaceutical compounds | |
| SI2364137T1 (sl) | Farmacevtska suspenzija | |
| ZA201104348B (en) | Pharmaceutical preparation | |
| GB0810615D0 (en) | Novel pharmaceutical | |
| GB0812969D0 (en) | Pharmaceutical compounds | |
| HU0800591D0 (en) | Stable pharmaceutical combination | |
| GB0816370D0 (en) | Pharmaceutical compounds | |
| GB0806527D0 (en) | Pharmaceutical compounds | |
| IL208387A0 (en) | Pharmaceutical composition | |
| GB0815972D0 (en) | Pharmaceutical preparation | |
| IL208953A0 (en) | Pharmaceutical combination | |
| ZA201006224B (en) | Pharmaceutical composition | |
| GB2464200B (en) | Pharmaceutical composition | |
| GB0810617D0 (en) | Novel pharmaceutical | |
| GB0817969D0 (en) | Pharmaceutical composition | |
| HU0800414D0 (en) | Pharmaceutical combination | |
| GB0804486D0 (en) | Novel pharmaceutical composituons | |
| GB0810217D0 (en) | Pharmaceutical formulations | |
| GB0813031D0 (en) | Pharmaceutical formulations | |
| GB0802576D0 (en) | Dosage form | |
| GB0817566D0 (en) | Pharmaceutical composition | |
| GB0817974D0 (en) | Pharmaceutical composition |